Antithymocyte immunoglobulin (rabbit) Not Yet Recruiting Phase 2 Trials for Malignancies, Hematologic / Bone Marrow Transplant (BMT) Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04395222Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation